The Stakes in Wisconsin's Supreme Court Race Are High. Here's Why.
Another Anti-Trump Media Narrative Is Showing No Effect With Voters
This Poll of American Jews About Trump and Israel Makes No Sense
Anti-Gunner Organization Just Made the Case for Trans-Identified People to Own Firearms
Here's What's at Stake for Republicans in Wisconsin's Supreme Court Elections
This Is the Harsh Reality of Unintentional Shootings Involving Children
More 'Extremely Dangerous Criminals' Have Been Sent to El Salvador
Brad Schimel vs. Susan Crawford: The Key Issues at Stake in Wisconsin’s Supreme...
Democratic Sen. Coons: 'Your Average Middle American' Is Too Stupid to Find Greenland...
Patronis Poised for Quick Impact in Congress
Markwayne Mullin Delivers Masterclass on 'Signalgate' During Sunday Show Appearance
The High Cost of Coastal Litigation: A Threat to Louisiana’s Economy and Trump’s...
DOGE Will Look Into Lawmakers Who Became 'Strangely Wealthy'
Another Poll Shows Democrats in Disarray Over How the Party Is Handling Trump
Trump's Answer to a Question About a Third-Term Is Sure to Trigger the...
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement